HomeTagsBiology

biology - Page 12

Stories from biology come first, newest first, then stories from connected topics (genomics, AI for science, AI Science & Health, drug discovery, Biotech, Hub: Tech for Good), each labelled with where it comes from. This view is not indexed by search engines.

Latest

Scientists Map How Andes Hantavirus Latches Onto Human Cells

Cryo-EM shows how the Andes hantavirus spike grips the PCDH1 receptor, revealing a pocket that could guide new antiviral drugs. No treatment exists yet.

Ai2 Releases Open Satellite Embeddings for Every 10m Pixel on Earth

Ai2's OlmoEarth v1.3 gives every 10-metre pixel on Earth a 128-number summary, with a free no-sign-in explorer. Its benchmark lead is self-reported.

Vaisala Says NVIDIA AI Stretches Lightning Warnings to Three Hours

Vaisala Xweather says NVIDIA's StormScope plus its lightning data will extend lightning forecasts from one hour to three. No accuracy figures yet.

KCL AI Spots DNA-Repair Defect in Ovarian Cancer From Routine Slides

A King's College London-led model reads routine tissue slides to flag HRD in ovarian cancer, with an AUC of 0.846. It is not yet a clinical test.

Enzyme-Embedded Plastics Broke Down in the Deep Sea, Study Says

University of Tokyo researchers report in Nature that compostable plastics with enzymes baked in degraded in sea water from the coast down to 5,503 metres.

Westlake Team Says Its Pinal AI Designs Working Proteins From Text

A Westlake University team says in Nature that its 16-billion-parameter Pinal model turned text prompts into proteins that worked in four lab tests.

Warp Sciences Says It Raised $215M for AI and Robot Chemistry Labs

Kevin Weil's Warp Sciences says it raised $215M, led by Lightspeed, to build a US chemistry lab using AI and robots; TechCrunch says it is valued at $865M.

OpenAI Buys Orchestra Bio to Put Drug-Programme Agents in Rosalind

OpenAI has bought Orchestra Bio, whose AI agents track studies and timelines in drug development, to fold into its Rosalind life-sciences suite. No price.

Anthropic Says Claude Designed Binders Against Scorpion Neurotoxins

Anthropic says Claude designed protein binders against scorpion neurotoxins, with 17 of 211 tested designs meeting its criteria. It claims no antivenom.

Lilly Taps Metis TechBio’s AI to Steer Medicines to Target Tissues

Metis TechBio will use AI to design tissue-targeted drug carriers for Eli Lilly. Upfront cash is low double-digit millions; milestones run up to $1.1bn.

Latest on TSN

Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.